Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hyejung Won | - |
dc.contributor.author | Won Mah | - |
dc.contributor.author | Eun Joon Kim | - |
dc.date.available | 2015-04-20T06:46:57Z | - |
dc.date.created | 2014-09-30 | - |
dc.date.issued | 2013-08 | - |
dc.identifier.issn | 1662-5099 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/1269 | - |
dc.description.abstract | Autism spectrum disorder (ASD) is a group of developmental disabilities characterized by impairments in social interaction and communication and restricted and repetitive interests/behaviors. Advances in human genomics have identified a large number of genetic variations associated with ASD. These associations are being rapidly verified by a growing number of studies using a variety of approaches, including mouse genetics. These studies have also identified key mechanisms underlying the pathogenesis of ASD, many of which involve synaptic dysfunctions, and have investigated novel, mechanism-based therapeutic strategies. This review will try to integrate these three key aspects of ASD research: human genetics, animal models, and potential treatments. Continued efforts in this direction should ultimately reveal core mechanisms that account for a larger fraction of ASD cases and identify neural mechanisms associated with specific ASD symptoms, providing important clues to efficient ASD treatment. | - |
dc.language | 영어 | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.title | Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000209202800018 | - |
dc.identifier.scopusid | 2-s2.0-84880642453 | - |
dc.identifier.rimsid | 5166 | ko |
dc.date.tcdate | 2018-10-01 | - |
dc.contributor.affiliatedAuthor | Won Mah | - |
dc.contributor.affiliatedAuthor | Eun Joon Kim | - |
dc.identifier.doi | 10.3389/fnmol.2013.00019 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN MOLECULAR NEUROSCIENCE, v.6, pp.19 | - |
dc.relation.isPartOf | FRONTIERS IN MOLECULAR NEUROSCIENCE | - |
dc.citation.title | FRONTIERS IN MOLECULAR NEUROSCIENCE | - |
dc.citation.volume | 6 | - |
dc.citation.startPage | 19 | - |
dc.date.scptcdate | 2018-10-01 | - |
dc.description.wostc | 58 | - |
dc.description.scptc | 63 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | HOMEOBOX-TRANSCRIPTION-FACTOR | - |
dc.subject.keywordPlus | SEVERE MYOCLONIC EPILEPSY | - |
dc.subject.keywordPlus | COUPLED GLYCINE RECEPTOR | - |
dc.subject.keywordPlus | GENOME-WIDE ASSOCIATION | - |
dc.subject.keywordPlus | EARLY BRAIN-DEVELOPMENT | - |
dc.subject.keywordPlus | REDUCED SODIUM CURRENT | - |
dc.subject.keywordPlus | COPY NUMBER VARIATION | - |
dc.subject.keywordPlus | LINKED MENTAL-RETARDATION | - |
dc.subject.keywordPlus | POSITIVE ALLOSTERIC MODULATOR | - |
dc.subject.keywordPlus | D-ASPARTATE RECEPTOR | - |
dc.subject.keywordAuthor | autism spectrum disorder | - |
dc.subject.keywordAuthor | therapeutics | - |
dc.subject.keywordAuthor | genetics | - |
dc.subject.keywordAuthor | animal model | - |
dc.subject.keywordAuthor | synapse | - |
dc.subject.keywordAuthor | synaptopathy | - |